The Recombinant Proteins Market Revenue was valued at USD 2.5 billion in 2023 and is projected to achieve a market size of USD 5.0 billion by 2032, growing at a robust CAGR of 7.6% over the forecast period of 2024-2032. Increasing applications in drug development, biotechnology research, and clinical therapies are driving the expansion of this market, marking recombinant proteins as pivotal to t..